| Revere Health | |
|
1175 E 50 S American Fork UT 84003-0000 | |
| (801) 429-8000 | |
| (801) 429-8150 |
| Full Name | Revere Health |
|---|---|
| Speciality | Clinic/center - Multi-specialty |
| Location | 1175 E 50 S, American Fork, Utah |
| Authorized Official Name and Position | Jed Bradley Harston (DIRECTOR OF MANAGED CARE) |
| Authorized Official Contact | 8018125012 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Revere Health 1055 N 500 W Attn: Credentialing Provo UT 84604-3305 Ph: (801) 354-8225 | Revere Health 1175 E 50 S American Fork UT 84003-0000 Ph: (801) 429-8000 |
| NPI Number | 1144439068 |
|---|---|
| Provider Enumeration Date | 05/21/2007 |
| Last Update Date | 03/07/2018 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144439068 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM1300X | Clinic/center - Multi-specialty | (* (Not Available)) | Primary |
News Archive
Think of the brain as a complex transportation hub, a place where neural traffic heads off in any number of directions to make connections while processing something as simple as a mother's smile.
New research indicates that a disruption of brain signals for reward and punishment contributes to increased pain sensitivity, known as hyperalgesia, in fibromyalgia patients. Results published in Arthritis & Rheumatism, a journal of the American College of Rheumatology, suggest that this altered brain processing might contribute to widespread pain and lack of response to opioid therapy in patients with fibromyalgia.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China today reported financial results for the three months ended March 31, 2015.
A selection of health policy stories from California, Missouri, Maine, Michigan, North Carolina, Texas and Georgia.
Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that repeated therapy cycles of its proprietary antibody, clivatuzumab tetraxetan, labeled with yttrium-90 plus low-dose gemcitabine, extended median overall survival.
› Verified 7 days ago
Cpt Ctr Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 98 N West State Rd, American Fork, UT 84003 Phone: 877-292-4242 | |
Medical Accident Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1248 E 90 N Ste 203, American Fork, UT 84003 Phone: 385-498-7506 Fax: 385-498-7507 | |
Ihc Health Services Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 170 N 1100 E, American Fork, UT 84003 Phone: 801-357-7414 | |
Greg W. Kofford, Dc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 246 S 1100 E, American Fork, UT 84003 Phone: 801-756-8833 Fax: 801-756-9014 | |
Provider Services Network, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 765 E 340 S Ste 206, American Fork, UT 84003 Phone: 801-893-1130 | |
Concord Premium Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 356 N 750 W, Ste D9-213, American Fork, UT 84003 Phone: 801-300-5159 |